From biosimilars to breakthroughs: regulatory convergence toward evidence-efficient development of monoclonal antibodies
Artículo
Acceso abierto
Artículo
DOAJ
Regulatory science governing monoclonal antibody development has undergone a profound transformation over the past decade, shifting from empiricism-driven paradigms toward evidence-efficient, mechanism-based frameworks g...
LCC LCC:Therapeutics. PharmacologyIdioma eng
Acceso abiertoRuta libre sin proxy. Acceso recomendado cuando no hay suscripción activa.
Open Access